Oxiconazole is an antifungal imidazole jointly developed by F. Hoffmann-LaRoche and Siegfried AG, both of Basel, Switzerland. It only has moderate activity against Aspergillus and is marketed for the treatment of dermatomycoses and vaginal candidiasis (Sochynsky and Hardcastle [ed.], Pharma Projects, p. a 299, May 1986).
Original paper: Mixich, G., and K. Thiele. 1979. Ein Beitrag zur stereospezifischen Synthese von antimykotisch wirksamen Imidazolyloximathern. Oxiconazol-nitrat (Sgd 301-76), ein neues Breitbandantimykotikum. Arneim. Forsch. 29:1510-1513.
